The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I expansion cohort trial to investigate the safety and clinical activity of avelumab (MSB0010718C) in patients with metastatic or locally advanced solid tumors.
 
Christopher Ryan Heery
No Relationships to Disclose
 
Jeffrey R. Infante
Consulting or Advisory Role - EMD Serono (Inst)
Research Funding - EMD Serono (Inst)
 
Nicholas Iannotti
No Relationships to Disclose
 
Karen Kelly
Consulting or Advisory Role - Boehringer Ingelheim; Clovis Oncology; Daiichi Sankyo; Genentech; Lilly; Synta; Transgene
Research Funding - EMD Serono; Genentech; Lilly; Millennium; Novartis; Proacta; Synta
Patents, Royalties, Other Intellectual Property - UpToDate
 
Petros Nikolinakos
Consulting or Advisory Role - Boehringer Ingelheim; Exelixis; Lilly
Speakers' Bureau - Boehringer Ingelheim
 
Anja von Heydebreck
Employment - EMD Serono
 
Kevin M. Chin
Employment - EMD Serono
 
James L. Gulley
Consulting or Advisory Role - Prime Oncology; TRM Oncology
Travel, Accommodations, Expenses - Prime Oncology; TRM Oncology